Clinical Trials

252 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07591090 2026-05-15

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

200 enrolled

Breast

Advanced Breast Cancer

NCT07586124 2026-05-14

Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

80 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT07564466 2026-05-11

A Study of SKB571 in Participants With Gastrointestinal Tumors

120 enrolled

Digestive System Neoplasms

NCT05554419 2026-04-13

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

Other hematologic neoplasm

184 enrolled

Leukemia, Myeloid, Acute

NCT06809946 2026-03-30

DEFLECT I

20 enrolled

Lung Neoplasms

NCT07491783 2026-03-24

Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial

52 enrolled

Head & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Sarcoma

NCT07342322 2026-01-15

A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma

25 enrolled

Sarcoma

NCT07311538 2025-12-31

Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies

56 enrolled

Advanced Gynecological Malignancies

NCT05106127 2025-12-08

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

28 enrolled

Gynecologic

Advanced Endometrial Cancer

NCT07247097 2025-11-25

ELDORADO

160 enrolled

Plasma cell

Multiple Myeloma

NCT07151872 2025-09-03

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

120 enrolled

CLDN18.2-positive Advanced Biliary Tract Cancer

NCT07076095 2025-07-21

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

200 enrolled

Small Cell Lung Carcinoma

NCT06951243 2025-04-30

A Trial of MHB088C in Advanced Extrapulmonary Neuroendocrine Cancer

40 enrolled

Endocrine

Advanced Extrapulmonary Neuroendocrine Cancer

NCT06942767 2025-04-27

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

100 enrolled

Tumor-Agnostic

Adenocarcinoma

NCT06892431 2025-03-25

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

150 enrolled

Head & Neck

Nasopharyngeal Neoplasms, Recurrence

NCT06760520 2025-01-08

Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal Cancer

40 enrolled

Locally Advanced Rectal Cancer

NCT06599775 2024-09-19

Study of Adebrelimab With Chemotherapy, Endoscopy and Sequential Chemoradiotherapy In Inoperable Esophageal Cancer

42 enrolled

Resectable Esophageal Squamous Cell Carcinoma

NCT06514027 2024-07-23

Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06508229 2024-07-18

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

65 enrolled

Esophageal Squamous Cell Carcinoma

NCT06500091 2024-07-15

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

54 enrolled

DermatologicSarcoma

Melanoma, Sarcoma

NCT06045767 2024-06-03

T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy in Advanced Non-small Lung Cancer

30 enrolled

Non-small Cell Lung Cancer Metastatic

NCT06426056 2024-05-23

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

64 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06299371 2024-03-07

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

36 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06149767 2023-11-29

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

26 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05996484 2023-08-21

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma

25 enrolled

Esophageal Neoplasms

NCT05821452 2023-04-20

Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma